Heyholder
‹ Disclosures

SK biopharmaceuticals Co., Ltd. Investor Relations Event

SK biopharmaceuticals Co., Ltd.
View original on DART ↗0 votes · 0 comments

AI summary · Not investment advice

SK Biopharmaceuticals will hold a conference call on November 5 to present its preliminary Q3 2026 business results.

Key facts

IR date and time
Nov 5, 2026
Audience
Domestic and overseas investors, analysts, etc.
Purpose
Announcement of preliminary Q3 2026 business results
Format
Earnings announcement via conference call
Main topics
Q3 2026 business results
Materials posting date
Nov 5, 2026
Materials location
https://www.skbp.com/
Live stream
Live audio webcast on the company website planned

Commentary

AI commentary · Not investment advice

What happened

SK Biopharmaceuticals will hold an investor relations session on November 5, 2026 at 10:30 to present its provisional business results for the third quarter of 2026. The audience is domestic and overseas investors, analysts and others, and the session will be run as a conference call. The main topic is the company's Q3 2026 results.

In the company's terms

The filing was received on November 2, 2026. The materials do not include any earnings figures, ratios or comparisons with prior periods, so the actual results will be available through the presentation materials released at the session.

What changes for shareholders

Shareholders can find the materials on the company website, https://www.skbp.com/, on the day of the session, November 5, 2026. A live audio webcast is also planned on the website.

Show Korean comments

Comments

No comments yet

Comments from shareholders will appear here.